Commentary

Video

NeuroOp Guru: Eye clues that signal neuroimaging in suspected neuro-Behcet disease

Fact checked by:

In cases with optic nerve hyperfluorescence or neurologic symptoms, prompt neuroimaging is warranted to rule out neuro-Behcet disease and guide multidisciplinary management.

In this episode of NeuroOp Guru, Andrew G. Lee, MD, and Andrew Carey, MD, discuss the overlap between Behcet uveitis and neurologic involvement in Behcet disease, emphasizing the importance of coordinated care between uveitis and neuro-ophthalmology specialists. Behcet is a multisystem autoimmune disease that commonly affects the skin, vasculature, GI tract, and eyes. While uveitis is a hallmark finding, neuro-Behcet—though less common—is potentially life-threatening.

A retrospective review1 discussed in the episode examined whether ocular signs and symptoms could predict CNS involvement. Key clinical red flags included persistent headaches (especially with meningeal signs), seizures, cranial nerve deficits (eg, diplopia, facial palsy), and optic neuritis. Less common were motor and cerebellar signs; sensory or cognitive symptoms were rare.

Importantly, even in the absence of overt neurologic symptoms, optic disc staining and leakage on fluorescein angiography increased the odds of neuro-Behcet (OR 5.4). This suggests that subtle optic nerve involvement seen during uveitis evaluation should prompt MRI consideration.

However, routine MRI for all patients with Behcet disease is discouraged due to the rarity of neuro involvement, imaging delays, and risks of incidental findings. Instead, imaging should be reserved for patients with neurologic symptoms, optic nerve signs, or high-risk fluorescein findings.

MRI findings may include venous sinus thrombosis, pachymeningitis, parenchymal enhancement, or white matter lesions mimicking multiple sclerosis. Enhancing or large white matter lesions are more concerning than age-related, non-enhancing changes.

Reference
  1. Borelli A, Behr J, Ruggeri M, Han M, Zhou Y, Foster CS. Indications for magnetic resonance imaging in patients with Behcet uveitis. J Neuroophthalmol. 2024;44(4):473-477. doi:10.1097/WNO.0000000000002018

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
© 2025 MJH Life Sciences

All rights reserved.